NIH-funded research R01 grant

Improving outcomes for corneal ulcers by detecting pathogens and antibiotic resistance

Official title: Improving Corneal Ulcer Outcomes with Unbiased Pathogen and Antimicrobial Resistance Detection

Funded at University of California, San Francisco · NIH-11088773 · Data updated 2026-11-12

This study is looking at infections in the eye that can cause serious vision problems, and it's for anyone who wants to help improve how these infections are diagnosed and treated by tracking the germs that cause them and how they respond to antibiotics in different places and times of the year.

More Ulcer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startMay 1, 2022
Project endApril 30, 2026
Funding year2025
Award (this year)$407,641
NIH project number5R01EY032861-04
Project IDNIH-11088773 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of all ages suffering from infectious corneal ulcers.

Less likely to help

Patients with corneal ulcers caused by non-infectious factors may not benefit from this research.

What this research studies

This research focuses on understanding infectious corneal ulcers, which can lead to significant vision loss. It aims to improve the diagnosis and treatment of these infections by conducting worldwide surveillance of the pathogens responsible for corneal ulcers and their resistance to antibiotics. The study will analyze how different geographic locations and seasonal changes affect the types of pathogens and their resistance profiles. Additionally, it will explore the local immune responses to these infections to better predict outcomes and tailor treatments.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for corneal ulcers, reducing the risk of vision loss for patients.

How similar studies have gone: Previous research has shown promise in improving treatment outcomes for infectious keratitis through better pathogen identification and understanding of antibiotic resistance.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Doan, Thuy a — University of California, San Francisco
  • Study coordinator: Doan, Thuy a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.